Sort   by:  
 Page size 
UnknownSafety, tolerability, and immunogenicity of a SARS-CoV-2 recombinant spike RBD protein vaccine: A randomised, double-blind, placebo-controlled, phase 1-2 clinical trial (ABDALA Study).
Not available
S-EPMC8994669 | biostudies-literature
UnknownA phase 3, randomised, double-blind, placebo-controlled clinical trial evaluation of the efficacy and safety of a SARS-CoV-2 recombinant spike RBD protein vaccine in adults (ABDALA-3 study).
Not available
S-EPMC10160525 | biostudies-literature
UnknownCost-Effective Method to Perform SARS-CoV-2 Variant Surveillance: Detection of Alpha, Gamma, Lambda, Delta, Epsilon, and Zeta in Argentina.
Not available
S-EPMC8703000 | biostudies-literature
UnknownColombian surgical outcomes study insights on perioperative mortality rate, a main indicator of the lancet commission on global surgery - a prospective cohort study.
Not available
S-EPMC11382124 | biostudies-literature
UnknownEffect of Intensive Blood-Pressure Treatment on Patient-Reported Outcomes.
Not available
S-EPMC5706112 | biostudies-literature
UnknownAssociation of Intensive vs Standard Blood Pressure Control With Magnetic Resonance Imaging Biomarkers of Alzheimer Disease: Secondary Analysis of the SPRINT MIND Randomized Trial.
Not available
S-EPMC7941253 | biostudies-literature
UnknownFinal Report of a Trial of Intensive versus Standard Blood-Pressure Control.
Not available
S-EPMC9907774 | biostudies-literature
UnknownChronic kidney disease, cerebral blood flow, and white matter volume in hypertensive adults.
Not available
S-EPMC4818564 | biostudies-literature
UnknownAdd-On Treatment With Zilebesiran for Inadequately Controlled Hypertension: The KARDIA-2 Randomized Clinical Trial.
Not available
S-EPMC12120674 | biostudies-literature
UnknownKidney Disease, Hypertension Treatment, and Cerebral Perfusion and Structure.
Not available
S-EPMC8926938 | biostudies-literature
Sort   by:  
 Page size